Curio Wealth’s Beam Therapeutics BEAM Stock Holding History

Curio Wealth’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$48	–	190
2026 Q1	$48	Hold	2	–	–	﹤0.01%	1132
2025 Q4	$56	Buy	+2	New	+$51	﹤0.01%	446

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Curio Wealth's BEAM Position: Q2 2026 in Review

Curio Wealth sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 2 shares — an estimated $48 sold.

Curio Wealth first reported a position in BEAM in Q4 2025 and held it in 2 quarters. The position peaked at $56 in Q4 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Curio Wealth reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
Curio Wealth sold 2 Beam Therapeutics shares in Q2 2026, an estimated $48.
Curio Wealth first reported a position in Beam Therapeutics in Q4 2025 and held it in 2 quarters.
Curio Wealth's Beam Therapeutics position peaked at $56 in Q4 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.